Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.

中文翻译：

---

心力衰竭中影像和循环生物标志物的整合：欧洲心脏病学会心力衰竭协会生物标志物和影像研究小组的共识文件

循环生物标志物和成像技术提供独立和互补的信息来指导心力衰竭 (HF) 的管理。欧洲心脏病学会 (ESC) 心力衰竭协会 (HFA) 的这份共识文件提出了当前与整合成像技术和生物标志物在 HF 中相关的循证适应症。该文件首先关注循环生物标志物和影像学结果在筛查、诊断、风险分层、治疗指导和监测等广泛领域的应用，然后讨论具体的具有挑战性的环境。在每个部分中，我们都会明确临床相关的建议并确定未来研究的方向。本文件的目标读者包括心脏病专家、